PHGE.U Insider Trading - BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t

Innsideraksjer

12 988 695 shares

Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Se høyest rangerte aksjer

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Se høyest rangerte aksjer

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

N/A

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

N/A

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider	Gjennomsnittlig fortjeneste (%)	Aksjer eid	Splitt justert

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til maks	Pris ved maks	Maks fortjeneste	Maks avkastning (%)
2023-05-22	Oron Assaf	3 192	0,2731	319	2,7310	872	289	0.6879	−652	−74,81
2023-05-19	Oron Assaf	6 521	0,2809	652	2,8090	1 832
2023-05-18	Oron Assaf	1 201	0,2727	120	2,7270	328
2023-02-27	OrbiMed Israel BioFund GP Limited Partnership	348 000	0,2450	34 800	2,4500	85 260
2021-07-28	SEKHRI PAUL J	12 500	4,0000	1 250	40,0000	50 000
2021-07-28	Sullivan Lynne Marie	12 500	4,0000	1 250	40,0000	50 000
2021-07-28	Solomon Jonathan Eitan	25 000	4,0000	2 500	40,0000	100 000

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t Insider Trades

Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til min	Pris ved min	Maks tap ungått ($)	Maks tap ungått (%)
2024-05-15	OrbiMed Israel BioFund GP Limited Partnership	24 344	0,3812	2 434	3,8120	9 280	100	0.1374	−8 945	−96,40
2023-11-29	Oron Assaf	2 056	0,3400	206	3,4000	699
2023-11-29	Oron Assaf	3 414	0,3500	341	3,5000	1 195
2023-11-29	Oron Assaf	5 444	0,4000	544	4,0000	2 178
2022-11-04	Ugwumba Chidozie	1 501	0,3780	150	3,7800	567
2022-11-03	Ugwumba Chidozie	2 000	0,3660	200	3,6600	732
2022-11-02	Ugwumba Chidozie	2 416	0,3590	242	3,5900	867
2022-11-01	Ugwumba Chidozie	1 300	0,3640	130	3,6400	473
2022-10-31	Ugwumba Chidozie	3 300	0,3710	330	3,7100	1 224

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil dato	Handels dato	Skjema	Innsider	Ticker	Verdipapirnavn	Kode	Direkte	Utøvelses pris	Enhets pris	Enheter endret	Verdi endret (1K)	Gjenværende Opsjoner	Gjenværende Aksjer
2025-04-21	2025-04-14	4/A	Bassan Merav	PHGE	Common Stock	A - Award	D			79 597			79 597
2025-04-21	2025-04-14	4/A	Solomon Jonathan Eitan	PHGE	Common Stock	A - Award	D			126 748			126 748
2025-04-21	2025-04-14	4/A	Wolfson Marina	PHGE	Common Stock	A - Award	D			68 545			68 545
2025-04-18	2025-04-14	4	Solomon Jonathan Eitan	PHGE	Common Stock	A - Award	D			126 748			126 748
2025-04-18	2025-04-14	4	Bassan Merav	PHGE	Common Stock	A - Award	D			79 597			79 597
2025-04-18	2025-04-14	4	Wolfson Marina	PHGE	Common Stock	A - Award	D			68 545			68 545
2025-03-04	2024-07-15	5	Cystic Fibrosis Foundation	PHGE	Common Stock, par value $0.0001 per share	C - Conversion	D			854 700			1 787 758
2025-03-03	2025-02-27	4	Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P.	PHGE	Common Stock	M - Exercise	I		0,9306	353 249	329		1 247 054
2025-03-03	2025-02-27	4	Flynn James E Through Deerfield Private Design Fund V, L.P.	PHGE	Common Stock	M - Exercise	I		0,9306	353 249	329		1 247 054
2024-09-18	2024-09-16	4	Bassan Merav	PHGE	Common Stock	A - Award	D			31 749			31 749
2024-09-18	2024-09-16	4	Oron Assaf	PHGE	Common Stock	A - Award	D			25 804			25 804
2024-09-18	2024-09-16	4	Solomon Jonathan Eitan	PHGE	Common Stock	A - Award	D			50 556			53 056
2024-07-17	2024-07-15	4	Flynn James E Through Deerfield Private Design Fund V, L.P.	PHGE	Common Stock	M - Exercise	I			5 883 000			8 938 049
2024-07-17	2024-07-15	4	Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P.	PHGE	Common Stock	M - Exercise	I			5 883 000			8 938 049
2024-05-20	2024-05-15	4	OrbiMed Israel BioFund GP Limited Partnership See footnotes	PHGE	Common Stock	S - Sale	I		0,3812	−24 344	−9		13 773 653
2024-05-20	2024-05-15	4	OrbiMed Israel BioFund GP Limited Partnership See footnotes	PHGE	Common Stock	X - Other	I		0,2440	9 280 408	2 264		13 797 997
2024-05-17	2024-05-15	4	Cystic Fibrosis Foundation	PHGE	Common Stock, par value $0.0001 per share	X - Other	D		0,0010	4 778 265	5		9 330 580
2024-03-26		3	Cystic Fibrosis Foundation	PHGE	Common Stock, par value $0.0001 per share		D						4 552 315
2024-03-19	2024-03-15	4	Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P.	PHGE	Common Stock	A - Award	I			3 055 049			3 055 049
2024-03-19	2024-03-15	4	Flynn James E Through Deerfield Private Design Fund V, L.P.	PHGE	Common Stock	A - Award	I			3 055 049			3 055 049
2023-12-01	2023-11-29	4	Oron Assaf	PHGE	Common Stock	S - Sale	D		0,3400	−2 056	−1		0
2023-12-01	2023-11-29	4	Oron Assaf	PHGE	Common Stock	S - Sale	D		0,3500	−3 414	−1		2 056
2023-12-01	2023-11-29	4	Oron Assaf	PHGE	Common Stock	S - Sale	D		0,4000	−5 444	−2		5 470
2023-05-24	2023-05-22	4	Oron Assaf	PHGE	Common Stock	P - Purchase	D		0,2731	3 192	1		10 914
2023-05-22	2023-05-19	4	Oron Assaf	PHGE	Common Stock	P - Purchase	D		0,2809	6 521	2		7 722
2023-05-22	2023-05-18	4	Oron Assaf	PHGE	Common Stock	P - Purchase	D		0,2727	1 201	0		1 201
2023-03-17	2023-02-27	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock	P - Purchase	I		0,2450	348 000	85		3 161 489
2022-11-14	2022-11-04	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3780	−1 501	−1		2 997 025
2022-11-14	2022-11-03	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3660	−2 000	−1		2 998 526
2022-11-14	2022-11-02	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3590	−2 416	−1		3 000 526
2022-11-14	2022-11-01	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3640	−1 300	−0		3 002 942
2022-11-14	2022-10-31	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3710	−3 300	−1		3 004 242
2022-11-14	2022-10-28	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3560	−1 526	−1		3 007 542
2022-11-14	2022-10-27	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3640	−1 505	−1		3 009 068
2022-11-14	2022-10-26	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3460	−12 500	−4		3 010 573
2022-11-14	2022-10-25	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3650	−3 072	−1		3 023 073
2022-11-14	2022-10-24	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3490	−5 900	−2		3 026 145
2022-11-14	2022-10-21	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3700	−5 400	−2		3 032 045
2022-11-14	2022-10-20	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3740	−6 636	−2		3 037 445
2022-11-14	2022-10-19	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3670	−4 501	−2		3 044 081
2022-11-14	2022-10-18	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3460	−15 300	−5		3 048 582
2022-11-14	2022-10-17	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3350	−8 098	−3		3 063 882
2022-11-14	2022-10-14	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3310	−3 420	−1		3 071 980
2022-11-14	2022-10-13	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3300	−11 314	−4		3 075 400
2022-11-14	2022-10-12	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3330	−9 700	−3		3 086 714
2022-11-14	2022-10-11	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3320	−5 988	−2		3 096 414
2022-11-14	2022-10-10	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3260	−10 043	−3		3 102 402
2022-11-14	2022-10-07	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3580	−24 708	−9		3 112 445
2022-11-14	2022-10-06	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4440	−25 098	−11		3 137 153
2022-11-14	2022-10-05	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4350	−46 785	−20		3 162 251
2022-11-14	2022-10-04	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3440	−19 200	−7		3 209 036
2022-11-14	2022-10-03	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3300	−15 022	−5		3 228 236
2022-11-14	2022-09-30	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3560	−8 662	−3		3 243 258
2022-11-14	2022-09-29	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3490	−3 300	−1		3 251 920
2022-11-14	2022-09-28	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3330	−15 649	−5		3 255 220
2022-11-14	2022-09-27	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3310	−4 866	−2		3 270 869
2022-11-14	2022-09-26	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3550	−17 528	−6		3 275 735
2022-11-14	2022-09-23	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,3740	−5 306	−2		3 293 263
2022-11-14	2022-09-22	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4130	−17 388	−7		3 298 569
2022-11-14	2022-09-21	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4270	−5 574	−2		3 315 957
2022-11-14	2022-09-20	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4510	−10 626	−5		3 321 531
2022-11-14	2022-09-19	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,4850	−13 870	−7		3 332 157
2022-11-14	2022-09-16	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5130	−3 200	−2		3 346 027
2022-11-14	2022-09-15	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5310	−3 900	−2		3 349 227
2022-11-14	2022-09-14	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5230	−2 301	−1		3 353 127
2022-11-14	2022-09-13	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5250	−2 201	−1		3 335 428
2022-11-14	2022-09-12	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5410	−1 700	−1		3 357 629
2022-11-14	2022-09-09	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5180	−13 219	−7		3 359 329
2022-11-14	2022-09-08	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5220	−4 592	−2		3 372 548
2022-11-14	2022-09-07	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5280	−8 846	−5		3 377 140
2022-11-14	2022-09-06	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5450	−6 403	−3		3 385 986
2022-11-14	2022-09-02	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5460	−2 001	−1		3 392 389
2022-11-14	2022-09-01	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5460	−8 297	−5		3 394 390
2022-11-14	2022-08-31	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5490	−4 540	−2		3 402 687
2022-11-14	2022-08-30	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5660	−13 487	−8		3 407 227
2022-11-14	2022-08-29	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,5710	−11 533	−7		3 420 714
2022-11-14	2022-08-26	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6160	−60 628	−37		3 432 247
2022-11-14	2022-08-25	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7180	−26 945	−19		3 492 875
2022-11-14	2022-08-24	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6520	−8 665	−6		3 519 820
2022-11-14	2022-08-23	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6380	−5 900	−4		3 528 485
2022-11-14	2022-08-22	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6570	−5 000	−3		3 534 385
2022-11-14	2022-08-19	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6390	−14 600	−9		3 539 385
2022-11-14	2022-08-18	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6830	−7 764	−5		3 553 985
2022-11-14	2022-08-17	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,6880	−21 335	−15		3 561 749
2022-11-14	2022-08-16	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7290	−8 563	−6		3 583 084
2022-11-14	2022-08-15	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7470	−7 200	−5		3 591 647
2022-11-14	2022-08-12	4	Ugwumba Chidozie By Symbiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7340	−11 406	−8		3 598 847
2022-11-14	2022-08-11	4	Ugwumba Chidozie By Symbiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7440	−9 824	−7		3 610 253
2022-11-14	2022-08-10	4	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock	S - Sale	I		0,7400	−17 769	−13		3 620 077
2022-03-31	2022-03-29	4	GROSSMAN JONAS	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		20 500		20 500
2022-03-31	2022-03-29	4	Sullivan Lynne Marie	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		20 500		20 500
2022-03-31	2022-03-29	4	Amusa Gbolahan	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		20 500		20 500
2022-03-31	2022-03-29	4	Greig Russell	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		41 000		41 000
2022-03-31	2022-03-29	4	Wolfson Marina	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		50 000		50 000
2022-03-31	2022-03-29	4	Solomon Jonathan Eitan	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		205 000		205 000
2022-03-31	2022-03-29	4	Bassan Merav	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		100 000		100 000
2022-03-31	2022-03-29	4	Moses Alan Charles	PHGE	Common Stock Options - Right to Buy	A - Award	D	1,41		20 500		20 500
2022-02-14	2021-12-31	4	Walton Thomas Layton By SymBiosis, LLC	PHGE	Warrants to purchase Common Stock	J - Other	I	5,00		−1 875 000		0
2022-02-14	2021-12-31	4	Walton Thomas Layton By SymBiosis, LLC	PHGE	Common Stock, $0.0001 par value	J - Other	I			−3 637 846			0
2022-02-14		3	Ugwumba Chidozie By SymBiosis, LLC	PHGE	Common Stock		I						3 637 846
2021-08-17	2021-07-26	4/A	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	P - Purchase	D			37 500			372 717
2021-08-17	2020-07-26	4/A	GROSSMAN JONAS	PHGE	Warrants to purchase Common Stock	P - Purchase	D	5,00		28 125		28 125
2021-08-09		3	Walton Thomas Layton By SymBiosis, LLC	PHGE	Common Stock, $0.0001 par value		I						3 637 846
2021-07-30	2021-07-28	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Warrants (Right to Buy)	P - Purchase	I	5,00		375 000		375 000
2021-07-30	2021-07-28	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.0001 par value	P - Purchase	I			500 000			2 813 489
2021-07-30	2021-07-28	4	Wolfson Marina	PHGE	Common Stock Warrant	P - Purchase	D	5,00		2 813		2 813
2021-07-30	2021-07-28	4	Wolfson Marina	PHGE	Common Stock	P - Purchase	D		4,0000	3 750	15		3 750
2021-07-30	2021-07-28	4	Sullivan Lynne Marie	PHGE	Common Stock Warrant	P - Purchase	D	5,00		9 375		9 375
2021-07-30	2021-07-28	4	Sullivan Lynne Marie	PHGE	Common Stock	P - Purchase	D		4,0000	12 500	50		12 500
2021-07-30	2021-07-28	4	Solomon Jonathan Eitan	PHGE	Common Stock Warrant	P - Purchase	D	5,00		18 750		18 750
2021-07-30	2021-07-28	4	Solomon Jonathan Eitan	PHGE	Common Stock	P - Purchase	D		4,0000	25 000	100		25 000
2021-07-30	2021-07-28	4	SEKHRI PAUL J	PHGE	Common Stock Warrant	P - Purchase	D	5,00		9 375		9 375
2021-07-30	2021-07-28	4	SEKHRI PAUL J	PHGE	Common Stock	P - Purchase	D		4,0000	12 500	50		12 500
2021-07-30	2021-07-28	4	Greig Russell	PHGE	Common Stock Warrant	P - Purchase	I	5,00		2 813		2 813
2021-07-30	2021-07-28	4	Greig Russell	PHGE	Common Stock	P - Purchase	I		4,0000	3 750	15		3 750
2021-07-30	2021-07-28	4	Moses Alan Charles	PHGE	Common Stock Warrant	P - Purchase	D	5,00		3 750		3 750
2021-07-30	2021-07-28	4	Moses Alan Charles	PHGE	Common Stock	P - Purchase	D		4,0000	5 000	20		5 000
2021-07-28	2021-07-26	4	GROSSMAN JONAS	PHGE	Warrants to purchase Common Stock	P - Purchase	D	5,00		28 125		28 125
2021-07-28	2021-07-26	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	P - Purchase	D			37 500			372 217
2021-07-28	2021-07-26	4	Amusa Gbolahan	PHGE	Warrants to purchase Common Stock	P - Purchase	D	5,00		18 750		18 750
2021-07-28	2021-07-26	4	Amusa Gbolahan	PHGE	Common Stock, par value $0.0001	P - Purchase	D			25 000			262 871
2021-04-01	2021-03-30	4	Puttagunta Sailaja	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		71 250		71 250
2021-04-01	2021-03-30	4	Greig Russell	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		30 400		30 400
2021-04-01	2021-03-30	4	SEKHRI PAUL J	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		15 200		15 200
2021-04-01	2021-03-30	4	Oron Assaf	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		33 250		33 250
2021-04-01	2021-03-30	4	Moses Alan Charles	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		15 200		15 200
2021-04-01	2021-03-30	4	Bassan Merav	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		47 500		47 500
2021-04-01	2021-03-30	4	Wolfson Marina	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		33 250		33 250
2021-04-01	2021-03-30	4	Sullivan Lynne Marie	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		15 200		15 200
2021-04-01	2021-03-30	4	Solomon Jonathan Eitan	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		152 000		152 000
2021-04-01	2021-03-30	4	GROSSMAN JONAS	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		15 200		15 200
2021-04-01	2021-03-30	4	Amusa Gbolahan	PHGE	Common Stock Options - Right to Buy	A - Award	D	7,02		15 200		15 200
2020-10-05	2020-10-02	4	SEKHRI PAUL J	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,44		16 000		16 000
2020-10-05	2020-10-02	4	Moses Alan Charles	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,44		16 000		16 000
2020-07-27	2020-07-13	4	Amusa Gbolahan	PHGE	Warrants to purchase Common Stock	J - Other	D	11,50		276 190		276 190
2020-07-27	2020-07-13	4	Amusa Gbolahan	PHGE	Common Stock, par value $0.0001	J - Other	D			95 148			237 871
2020-07-22	2020-07-13	4	PROPPER KERRY By Mountain Wood, LLC	PHGE	Warrants to purchase Common Stock	J - Other	I	11,50		−2 900 000		0
2020-07-22	2020-07-13	4	PROPPER KERRY	PHGE	Warrants to purchase Common Stock	J - Other	D	11,50		631 786		631 786
2020-07-22	2020-07-13	4	PROPPER KERRY By Mountain Wood, LLC	PHGE	Common Stock, par value $0.0001	J - Other	I			−999 058			0
2020-07-22	2020-07-13	4	PROPPER KERRY	PHGE	Common Stock, par value $0.0001	J - Other	D			217 652			260 771
2020-07-22	2020-07-13	4	GROSSMAN JONAS	PHGE	Warrants to purchase Common Stock	J - Other	D	11,50		666 310		716 439
2020-07-22	2020-07-13	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	J - Other	D			229 545			335 217
2020-07-22	2020-06-18	4	GROSSMAN JONAS By Ravenna LLC	PHGE	Common Stock, par value $0.0001	J - Other	I			−45 275			0
2020-06-12	2020-06-10	4	PROPPER KERRY By Mountain Wood, LLC	PHGE	Common Stock, par value $0.0001	J - Other	I			999 058			999 058
2020-06-12	2020-06-10	4	PROPPER KERRY	PHGE	Common Stock, par value $0.0001	J - Other	D			43 119			43 119
2020-06-12	2020-06-10	4	Amusa Gbolahan	PHGE	Common Stock, par value $0.0001	J - Other	D			142 723			142 723
2020-06-12	2020-06-10	4	GROSSMAN JONAS By Ravenna LLC	PHGE	Common Stock, par value $0.0001	J - Other	I			42 275			45 275
2020-06-12	2020-06-10	4	GROSSMAN JONAS By Chardan Investments, LLC	PHGE	Common Stock, par value $0.0001	J - Other	I			−1 707 500			0
2020-06-12	2020-06-10	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	J - Other	D			99 172			105 672
2020-03-27	2020-03-25	4	Solomon Jonathan Eitan	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		144 000		144 000
2020-03-27	2020-03-25	4	GROSSMAN JONAS	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		16 000		16 000
2020-03-27	2020-03-25	4	Chimovits Erez	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		16 000		16 000
2020-03-27	2020-03-25	4	Amusa Gbolahan	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		16 000		16 000
2020-03-27	2020-03-25	4	Oron Assaf	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		31 500		31 500
2020-03-27	2020-03-25	4	Sullivan Lynne Marie	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		16 000		16 000
2020-03-27	2020-03-25	4	Breski Yaron	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		16 000		16 000
2020-03-27	2020-03-25	4	Wolfson Marina	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		36 000		36 000
2020-03-27	2020-03-25	4	Puttagunta Sailaja	PHGE	Common Stock Options - Right to Buy	A - Award	I	6,21		67 500		67 500
2020-03-27	2020-03-25	4	Greig Russell	PHGE	Common Stock Options - Right to Buy	A - Award	D	6,21		32 000		32 000
2019-12-30	2019-12-20	4	GROSSMAN JONAS	PHGE	Warrants	J - Other	I	11,50		−2 900 000		0
2019-12-20	2019-12-19	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9000	3 500	31		2 313 489
2019-12-20	2019-12-18	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9300	500	4		2 309 989
2019-12-20	2019-12-19	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9000	3 500	31		2 313 489
2019-12-20	2019-12-18	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9300	500	4		2 309 989
2019-12-12	2019-12-11	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9200	5 400	48		2 309 489
2019-12-12	2019-12-10	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,7500	3 400	30		2 304 089
2019-12-12	2019-12-11	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,9200	5 400	48		2 309 489
2019-12-12	2019-12-10	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,7500	3 400	30		2 304 089
2019-12-09	2019-12-09	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,6800	6 000	52		2 300 689
2019-12-09	2019-12-06	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,0000	800	6		2 294 689
2019-12-09	2019-12-05	4	OrbiMed Israel BioFund GP Limited Partnership See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		7,9900	3 400	27		2 293 889
2019-12-09	2019-12-09	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,6800	6 000	52		2 300 689
2019-12-09	2019-12-06	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		8,0000	800	6		2 294 689
2019-12-09	2019-12-05	4	Chimovits Erez See Footnotes	PHGE	Common Stock, $0.001 par value	P - Purchase	I		7,9900	3 400	27		2 293 889
2019-11-20	2019-11-20	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	P - Purchase	D		8,0040	1 400	11		6 500
2019-11-20	2019-11-19	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	P - Purchase	D		7,5730	4 100	31		5 100
2019-11-20	2019-11-18	4	GROSSMAN JONAS	PHGE	Warrants	P - Purchase	D	11,50	0,5990	50 129	30	50 129
2019-11-20	2019-11-18	4	GROSSMAN JONAS	PHGE	Common Stock, par value $0.0001	P - Purchase	D		6,9890	1 000	7		1 000
2019-11-07		3	Chimovits Erez See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	Chimovits Erez See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	Chimovits Erez See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	OrbiMed Israel GP Ltd. See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	OrbiMed Israel GP Ltd. See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	OrbiMed Israel GP Ltd. See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-07		3	OrbiMed Israel GP Ltd. See Footnotes	PHGE	Common Stock		I						4 580 980
2019-11-05		3	Takeda Ventures, Inc.	PHGE	Common Stock		I						4 941 870
2019-11-05		3	Takeda Ventures, Inc.	PHGE	Common Stock		I						4 941 870
2019-11-05		3	Takeda Ventures, Inc.	PHGE	Common Stock		I						4 941 870
2019-11-05		3	Takeda Ventures, Inc.	PHGE	Common Stock		I						4 941 870
2019-09-19		3	MMCAP International Inc. SPC	CHAC	Common Stock		D						3 400 000
2019-09-19		3	MMCAP International Inc. SPC	CHAC	Common Stock		D						3 400 000
2019-09-19		3	MMCAP International Inc. SPC	CHAC	Common Stock		D						3 400 000
2018-12-21		3	Gnedy Elliot	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-21		3	Gnedy Elliot	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-21		3	Gnedy Elliot	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-19	2018-12-18	4	GROSSMAN JONAS	CHAC	Warrants	P - Purchase	I	11,50	0,4000	2 900 000	1 160	2 900 000
2018-12-14		3	Kusseluk Eric	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Kusseluk Eric	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Kusseluk Eric	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	GROSSMAN JONAS	CHAC	Common Stock, par value $0.0001		I						3 940 000
2018-12-14		3	GROSSMAN JONAS	CHAC	Common Stock, par value $0.0001		I						3 940 000
2018-12-14		3	GROSSMAN JONAS	CHAC	Common Stock, par value $0.0001		I						3 940 000
2018-12-14		3	Rossen Matthew	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Rossen Matthew	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Rossen Matthew	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	RICE YEHUDA MICHAEL	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	RICE YEHUDA MICHAEL	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	RICE YEHUDA MICHAEL	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Chardan Investments, LLC	CHAC	Common Stock, par value $0.0001		D						3 940 000
2018-12-14		3	Chardan Investments, LLC	CHAC	Common Stock, par value $0.0001		D						3 940 000
2018-12-14		3	Chardan Investments, LLC	CHAC	Common Stock, par value $0.0001		D						3 940 000
2018-12-14		3	Giroux Richard	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Giroux Richard	CHAC	Common Stock, par value $0.0001		D						15 000
2018-12-14		3	Giroux Richard	CHAC	Common Stock, par value $0.0001		D						15 000

Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.

Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)

Konvertering av derivat

Salg eller overføring av verdipapirer tilbake til selskapet

Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet

Gave av verdipapirer fra eller til insidere

Aksjebytting og lignende sikringsavtaler

Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)

En transaksjon frivilig rapportert på Skjema 4

Annet (med en fotnote som beskriver transaksjonen)

PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t - Insider Trading and Ownership Report - SEC Form 3, 4, 5